首页> 美国卫生研究院文献>Journal of Allergy >Occupational Asthma: New Low-Molecular-Weight Causal Agents 2000–2010
【2h】

Occupational Asthma: New Low-Molecular-Weight Causal Agents 2000–2010

机译:职业性哮喘:新型低分子因果药物2000–2010年

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. More than 400 agents have been documented as causing occupational asthma (OA). The list of low-molecular-weight (LMW) agents that have been identified as potential causes of OA is constantly expanding, emphasizing the need to continually update our knowledge by reviewing the literature. Objective. The objective of this paper was to identify all new LMW agents causing occupational asthma reported during the period 2000–2010. Methods. A Medline search was performed using the keywords occupational asthma, new allergens, new causes, and low-molecular-weight agents. Results. We found 39 publications describing 41 new LMW causal agents, which belonged to the following categories: drugs (n = 12), wood dust (n = 11), chemicals (n = 8), metals (n = 4), biocides (n = 3), and miscellaneous (n = 3). The diagnosis of OA was confirmed through SIC for 35 of 41 agents, peak expiratory flow monitoring for three (3) agents, and the clinical history alone for three (3) agents. Immunological tests provided evidence supporting an IgE-mediated mechanism for eight (8) (20%) of the newly described agents. Conclusion. This paper highlights the importance of being alert to the occurrence of new LMW sensitizers, which can elicit OA. The immunological mechanism is explained by a type I hypersensitivity reaction in 20% of all newly described LMW agents.
机译:背景。据记录,有400多种病原引起职业性哮喘(OA)。已经被确定为OA潜在病因的低分子量(LMW)药物的名单正在不断扩大,强调需要通过回顾文献来不断更新我们的知识。目的。本文的目的是确定在2000年至2010年期间报告的所有新的引起职业性哮喘的LMW药物。方法。使用关键词职业性哮喘,新变应原,新原因和低分子量药物进行了Medline搜索。结果。我们发现39种出版物描述了41种新的LMW致病因子,它们属于以下类别:药物(n = 12),木屑(n = 11),化学品(n = 8),金属(n = 4),杀生物剂(n = 3)和其他(n = 3)。通过SIC对41种药物中的35种,三(3)种药物的峰值呼气流量监测以及三(3)种药物的临床病史进行了OA诊断。免疫学测试提供了证据支持八(8)(20%)的新描述药物的IgE介导机制。结论。本文强调了警惕新的LMW敏化剂的出现的重要性,这会引起OA。免疫机制由所有新描述的LMW药物中20%的I型超敏反应解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号